Arkolith/Insider Trading/ALZN/Form 4

Ault Milton C III

Director, 10% OwnerAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed May 14, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6K
Net Open-Market Flow
-$6K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 12, 2025Sell(S)11$5.28$582K
May 12, 2025Sell(S)1K$5.06$6K8K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-007625) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML